Ironwood Pharmaceuticals Progresses Vascular and Fibrotic Disease Platform with Positive Top-Line Phase Ia Data on Soluble Guanylate Cyclase Stimulator IW-1701
Go back to Ironwood Pharmaceuticals Progresses Vascular and Fibrotic Disease Platform with Positive Top-Line Phase Ia Data on Soluble Guanylate Cyclase Stimulator IW-1701| IRONWOOD PHARMA-A (NASDAQ: IRWD) | Delayed: 4.23 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.23 | 52 Week High | $16.89 | |||
| Open | $4.23 | 52 Week Low | $7.35 | |||
| Day High | $4.23 | P/E | N/A | |||
| Day Low | $4.23 | EPS | $-2.35 | |||
| Volume | 521 | |||||
